| Year |
Citation |
Score |
| 2019 |
Kong T, Xue Y, Cencic R, Zhu X, Monast A, Fu Z, Pilon V, Sangwan V, Guiot MC, Foulkes WD, Porco JA, Park M, Pelletier J, Huang S. eIF4A inhibitors suppress cell cycle feedback response and acquired resistance to CDK4/6 inhibition in cancer. Molecular Cancer Therapeutics. PMID 31395685 DOI: 10.1158/1535-7163.Mct-19-0162 |
0.314 |
|
| 2019 |
Xue Y, Meehan B, Macdonald E, Venneti S, Wang XQD, Witkowski L, Jelinic P, Kong T, Martinez D, Morin G, Firlit M, Abedini A, Johnson RM, Cencic R, Patibandla J, ... ... Guiot MC, et al. CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. Nature Communications. 10: 558. PMID 30718512 DOI: 10.1038/S41467-018-06958-9 |
0.304 |
|
| 2019 |
Xue Y, Meehan B, Fu Z, Wang XQD, Fiset PO, Rieker R, Levins C, Kong T, Zhu X, Morin G, Skerritt L, Herpel E, Venneti S, Martinez D, Judkins AR, ... ... Guiot MC, et al. SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer. Nature Communications. 10: 557. PMID 30718506 DOI: 10.1038/S41467-019-08380-1 |
0.301 |
|
| 2018 |
Shakir SI, Souhami L, Petrecca K, Mansure JJ, Singh K, Panet-Raymond V, Shenouda G, Al-Odaini AA, Abdulkarim B, Guiot MC. Prognostic factors for progression in atypical meningioma. Journal of Neurosurgery. 1-9. PMID 29350599 DOI: 10.3171/2017.6.Jns17120 |
0.34 |
|
| 2016 |
Jermyn M, Desroches J, Mercier J, Tremblay MA, St-Arnaud K, Guiot MC, Petrecca K, Leblond F. Neural networks improve brain cancer detection with Raman spectroscopy in the presence of operating room light artifacts. Journal of Biomedical Optics. 21: 94002. PMID 27604560 DOI: 10.1117/1.Jbo.21.9.094002 |
0.324 |
|
| 2016 |
Jermyn M, Desroches J, Mercier J, St-Arnaud K, Guiot M, Petrecca K, Leblond F. Neural networks improve brain cancer detection with Raman spectroscopy in the presence of light artifacts Proceedings of Spie. 9690. DOI: 10.1117/12.2208892 |
0.328 |
|
| 2015 |
Gavino C, Hamel N, Zeng JB, Legault C, Guiot MC, Chankowsky J, Lejtenyi D, Lemire M, Alarie I, Dufresne S, Boursiquot JN, McIntosh F, Langelier M, Behr MA, Sheppard DC, et al. Impaired RASGRF1/ERK-mediated GM-CSF response characterizes CARD9 deficiency in French-Canadians. The Journal of Allergy and Clinical Immunology. PMID 26521038 DOI: 10.1016/J.Jaci.2015.09.016 |
0.311 |
|
| 2015 |
Jermyn M, Mok K, Mercier J, Desroches J, Pichette J, Saint-Arnaud K, Bernstein L, Guiot MC, Petrecca K, Leblond F. Intraoperative brain cancer detection with Raman spectroscopy in humans. Science Translational Medicine. 7: 274ra19. PMID 25673764 DOI: 10.1126/Scitranslmed.Aaa2384 |
0.336 |
|
| 2015 |
Jermyn M, Mok K, Mercier J, Desroches J, Pichette J, Saint-Arnaud K, Guiot MC, Petrecca K, Leblond F. Intraoperative detection of glioma invasion beyond MRI enhancement with Raman spectroscopy in humans Progress in Biomedical Optics and Imaging - Proceedings of Spie. 9318. DOI: 10.1117/12.2075660 |
0.367 |
|
| 2010 |
Maestro RD, Siu V, Sadr MS, Alshami J, Sabau C, Sadr ES, Guiot M, Galarneau A, Pouliot J, Greaves K. Safety and efficacy of presurgical neoadjuvant low-dose temozolomide in glioma patients. Journal of Clinical Oncology. 28. DOI: 10.1200/Jco.2010.28.15_Suppl.E12510 |
0.318 |
|
| 2009 |
El-Hateer H, Souhami L, Roberge D, Maestro RD, Leblanc R, Eldebawy E, Muanza T, Melançon D, Kavan P, Guiot MC. Low-grade oligodendroglioma: an indolent but incurable disease? Clinical article. Journal of Neurosurgery. 111: 265-71. PMID 19284232 DOI: 10.3171/2008.11.Jns08983 |
0.326 |
|
| 2009 |
Panet-Raymond V, Souhami L, Roberge D, Kavan P, Shakibnia L, Muanza T, Lambert C, Leblanc R, Del Maestro R, Guiot MC, Shenouda G. Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis. International Journal of Radiation Oncology, Biology, Physics. 73: 473-8. PMID 18554821 DOI: 10.1016/J.Ijrobp.2008.04.030 |
0.322 |
|
| 2008 |
Ang C, Hauerstock D, Guiot MC, Kasymjanova G, Roberge D, Kavan P, Muanza T. Characteristics and outcomes of medulloblastoma in adults. Pediatric Blood & Cancer. 51: 603-7. PMID 18649371 DOI: 10.1002/Pbc.21588 |
0.318 |
|
| 2008 |
Huang F, Kavan P, Guiot MC, Markovic Y, Roberge D. When temozolomide alone fails: adding procarbazine in salvage therapy of glioma. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 35: 192-7. PMID 18574933 DOI: 10.1017/S0317167100008623 |
0.323 |
|
| Show low-probability matches. |